← Leaderboards
Irene Cortes-Puch
Eicosis, Llc
$2,591,036
Attributed
$4,902,935
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,902,935 · 2
By mechanism
UH3$4,623,799 · 1
R43$279,136 · 1
Top collaborators
- Bruce D Hammock2 shared
Others in their field
Other Rising Stars on “Safety”
- Angee Greer · Ppd Development Lp$82,531,927
- Jessica Ellis · Technical Resources International, Inc.$46,538,640
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Lauren Miller · Technical Resources International, Inc.$31,120,905
- Suma Babu · Massachusetts General Hospital$26,348,733
Research focus
SafetyBiologicalMetabolismDrug KineticsAnalgesicsFatty AcidsEpoxide HydrolaseLipidsPolyunsaturated Fatty AcidsSamplingPreventClinical TrialsDoseInhibitorEnzymesBehavioral OutcomeDesignAddictionAttenuatedComparative EfficacyCyclic GmpChronic Pain ReliefChronic Pain ManagementClinical Development
Grant awards (3)
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$2,481,856
UH3 · FY2025 · DA · contact PI
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$2,141,943
UH3 · FY2024 · DA · contact PI
Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling$279,136
R43 · FY2022 · HL · contact PI